Pfizer Inc. and BioNTech SE’s Covid-19 vaccine gets approval from US for children aged 5 to 11

(G.N.S) Dt. 30 Washington The U.S. Food and Drug Administration (FDA) has approved for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to <12 years). For this age group, the vaccine is to be administered in a two-dose regimen